The 40Hz audiovisual stimulation therapy for Alzheimer‘s disease was proposed by the research team from the Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology (MIT). In December 2016, this research team published a study titled “Gamma frequency entrainment attenuates amyloid load and modifies microglia” in the journal “Nature.” This study revealed that “40Hz flickering light” can…

Hukui sincerely invites you to join us in MD&M WEST 2024. At this show, we will present our core products and innovative solutions. It would be a great pleasure to meet you at the exhibition!

On December 13th, HUKUI Biotechnology Co., Ltd. (referred to as HUKUI) celebrated its 10th anniversary at the Courtyard by Marriott Taipei. The event brought together renowned enterprises, suppliers, and partners from various industries such as finance, manufacturing, and healthcare to commemorate this remarkable milestone.

As the COVID-19 outbreak has spread in the past 2 years, the global healthcare providers have been experiencing severe operational and clinical challenges, including routine appointment and surgery cancellations, cross infections between patients and caregivers, and hospital staff shortage. This had a great impact on the utilization and procurement of diagnostic devices and surgical instruments.

Established by the Chairman, John Hsuan, 8 years ago, HKBio has delved into the regulatory services and contract design and manufacturing services for almost a decade. In 2021, HKBio had a record-breaking year due to the rapid growth in Taiwanese corporate rapid testing needs and sales growth in China, achieving more than 6 fold annual revenue growth and quarterly break-even…

Medical device design and development are highly technical and specialized. It is even more challenging for an early stage medical device startup to have the necessary resources to build an end-to-end manufacturing facility, from small scale prototypes to large scale mass production, not to mention the cost of clinical trial and patent maintenance. This is exactly the reason why medical…

A few decades ago, medical device OEMs single-handedly developed and manufactured their medical innovations. The advantage of this kind of operation is the ability to have complete control over design and development, small pilot production, and large scale mass production. However, a large-scale ISO13485 compliant GMP manufacturing facility represents an enormous capital commitment.

In 2020, the epidemic of COVID-19 has spread in the whole world, and COVID-19 diagnostic kit is definitely a purchasing point from the beginning. HUKUI Bio has been authorized by two Taiwan nucleic acid diagnostic kit factories to begin providing COVID-19 diagnostic kit for Europe, ASEAN and South America markets, hoping to satisfy their local medical resources.